Adherence in bronchial asthma and chronic obstructive pulmonary disease: from a problem to a solution


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Chronic obstructive pulmonary disease (COPD) and bronchial asthma (BA) remain the leading chronic broncho-obstructive pathology requiring lifelong use of inhaled medicines continuously or as needed depending on the severity of the disease. The key element in the treatment is the patient’s compliance with doctor’s recommendations both on drug therapy and on lifestyle and behavior, that is, adherence. A review of current positions on classification, methods of detection and methods of correcting intentional and unintentional non-adherence, as well as the results of authors’ own research of229 patients with BA and 154 patients with COPD is presented. Authors’ own data showed higher adherence of patients with controlled BA (75.9% vs 51.2% with uncontrolled BA). In COPD, adherence was significantly lower, but patients with more pronounced impaired forced expiratory parameters had the highest frequency of adherence. According to the spiromet-ric data (GOLD-2006), only 9.1% of patients with I degree of severity adhered to medical prescriptions, with II degree - only 26.1%, with III - 25.4%, and with IV degree - 43, 3%. Treatment adherence in COPD and BA remains low, but there are methods for its improvement.

Full Text

Restricted Access

About the authors

Alexander A. Vizel

Kazan State Medical University

MD, Prof., Head of the Department of Phthisiopulmonology, Chief Specialist-Pulmonologist of the Ministry of Health of the Republic of Tatarstan, Honored Doctor of Republic of Tatarstan, Laureate of the State Prize of the Republic of Tatarstan in the field of Science and Technology

I. Yu Vizel

Kazan State Medical University; Central Tuberculosis Research Institute

I. N Salakhova

Kazan State Medical University

A. R Vafina

Kazan State Medical University

References

  1. Global Strategy for Asthma Management and Prevention. Global Initiative for Asthma (GINA). Updated 2018. URL: http://www.ginasthma.org (February10, 2019).
  2. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2019. URL: http:// goldcopd.org (February 01, 2019).
  3. Gregoriano C., Dieterle T., Breitenstein A.L., et al. Use and inhalation technique of inhaled medication in patients with asthma and COPD: data from a randomized controlled trial. Respir Res. 2018;19(1):237. doi: 10.1106/112/31-918-0986-9.
  4. Nolte E., McKee M. Caring for people with chronic conditions: A health system perspective. World Health Organization, 2008. http://www.euro.who.int/_ data/assets/pdf_file/0002/92428/E91878.pdf (February 01, 2019).
  5. World Health Organization. Adherence to long-term therapies: Evidence for action. http://apps.who.int/ medicinedocs/pdf/s4883e/ s4883e.pdf. (February 01, 2019).
  6. Aronson J.K. Compliance, concordance, adherence. Br J. Clin Pharmacol. 2007;23(4):383-84. doi: 10.1111/j.1325-2125.2007.02893.x.
  7. Clifford S., Barber N., Horne R. Understanding different beliefs held by adherers, unintentional non-adherers, and intentional non-adherers: Application of the Necessity-Concerns Framework. J. Psychosom Res. 2008;24:41-2. Doi: 10.1012/j. jpsychores.2007.05.004
  8. Wu A.C., Butler M.G., Li L., et al. Primary adherence to controller medications for asthma is poor. Ann Am Thorac Soc. 2015;12(2):121-22.
  9. Normansell R., Kew K.M., Stovold E. Interventions to improve adherence to inhaled steroids for asthma. Cochrane Database Syst Rev. 2017;18(4):CD012222.
  10. George M. Adherence in Asthma and COPD: New strategies for an old problem. Respir Care. 2018;23(2):818-31. doi: 10.4187/respcare.05905.
  11. van Boven J.F.M., Trappenburg J.C.A., van der Molen T., Chavannes J.N.H. Towards tailored and targeted adherence assessment to optimize asthma management. NPJ. Prim Care Respir Med. 2015;25:15046. doi: 10.1038/npjpcrm.2015.46.
  12. MacIntyre C.R., Goebel K. Patient knows best: Blinded assessment of nonadherence with antituberculous therapy by physicians, nurses, and patients compared with urine drug levels. Prev Med. 2005;40(1):41-5.
  13. Sherman J., Hutson A., Baumstein S., Hendeles L. Telephoning the patient's pharmacy to assess adherence with asthma medications by measuring refill rate for prescriptions. J Pediatr. 2000;136:532 36. Doi: https://doi.org/10.3928/0090-4481 20001201-11
  14. Morisky D.E. Green L.W., Levine D.M. Concurrent and predictive validity of self-reported measure of medical adherence. Med Care. 1986;24(1):67-73.
  15. Plaza V., Fern ndez-Rodrguez C., Melero C., et al.; TAI Study Group. Validation of the 'Test of the Adherence to Inhalers' (TAI) for asthma and COPD patients. J. Aerosol Med Pulm Drug Deliv. 2016;29(2):142-52. doi: 10.1089/jamp.2015.1212.
  16. Alhewiti A. Adherence to long-term therapies and beliefs about medications. Int. J. Family Med. 2014;2014:479596. doi: 10.1155/2014/479596.
  17. Engelkes M., Janssens H.M., de Jongste J.C., et al. Prescription patterns, adherence and characteristics of non-adherence in children with asthma in primary care. Pediatr Allergy Immunol. 2016;27(2):201-8. doi: 10.1111/pai.12507.
  18. Mueller S., Wilke T., Bechtel B., et al. Non-persistence and non-adherence to long-acting COPD medication therapy: A retrospective cohort study based on a large German claims dataset. Respir Med. 2017;122:1-11. doi: 10.1016/j.rmed.2016.11.008.
  19. Feehan M., Ranker L., Durante R., et al. Adherence to controller asthma medications: 6-month prevalence across a US community pharmacy chain. J. Clin Pharm Ther 2015;40:590-93.
  20. Rackley J. Smart inhalers: Pros and cons. Health Central. https://www.healthcentral.com/article/smart-inhalers-pros-and-cons. (February 01,2019).
  21. Restrepo R.D., Alvarez M.T., Wittnebel L.D., et al. Medication adherence issues in patients treated for COPD. Int J. Chron Obstruct Pulmon Dis. 2008:3(8)331-84.
  22. Leiva-Fernandez J., leiva-Fernandez F., Garca-Ruiz A., et al. Efficacy of a multifactorial intervention on therapeutic adherence in patients with chronic obstructive pulmonary disease (COPD): A randomized controlled trial. BMC Pulm Med. 2014;14:70. doi: 10.1182/1471-2422-14-70.
  23. Toy E.L., Beaulieu N.U., McHale J.M., et al. Treatment of COPD: Relationships between daily dosing frequency, adherence, resource use, and costs. Respir Med. 2011;105(3):435-44. Doi: 10.1012/j. rmed.2010.09.002.
  24. Wolever R.Q., Simmons L.A., Sforzo G.A., et al. A systematic review of the literature on health and wellness coaching: Defining a key behavioral intervention in healthcare. Glob. Adv Health Med. 2013;2(4):38-57. doi: 10.7453/gahmj.2013.042.
  25. Apter A.J., Morales K.H., Han X., et al. A patient advocate to facilitate access and improve communication, care, and outcomes in adults with moderate or severe asthma: Rationale, design, and methods of a randomized controlled trial. Contemp Clin Trials. 2017;52:34-45.
  26. Wilson S.R., Strub P., Buist A.S., et al. Shared treatment decision making improves adherence and outcomes in poorly controlled asthma. Am J. Respir Crit Care Med. 2010;181(2):522-77. doi: 10.1124/rccm.200902-0907OC.
  27. Miller W.R., Rollnick S. Motivational interviewing: Helping people change. 3rd ed. New York: Guilford Press, 2013. 482 p.
  28. Elwyn G., Dehlendorf C., Epstein R.M., et al. Shared decision making and motivational interviewing: Achieving patient-centered care across the spectrum of health care problems. Ann Fam Med. 2014;12(3):270-75. doi: 10.1370/afm.1215.
  29. Фофанова Т.В., Агеев Ф.Т., Смирнова М.Д. и др. Отечественный опросник приверженности терапии: апробация и применение в амбулаторной практике. Системные гипертензии. 2014;2:13-2.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies